Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Dow Jones Rises After Jobs Data; U.S. Payrolls Report On Deck

The Dow Jones Industrial Average rose 250 points Thursday after key jobs data came out early, ahead of Friday's pivotal payrolls report.

Investors Business Daily

Dow Jones Turns Lower Ahead Of Fed Minutes

The Dow Jones Industrial Average fell Wednesday morning ahead of the highly-anticipated release of the minutes from last month's Fed meeting.

Investors Business Daily

How a Texas town is making itself into an epicenter of the US semiconductor universe

In downtown Sherman, Texas, markers explain the city’s past and restaurants and coffee shops boast about the historic buildings they call home.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Dives; Tesla Skids On Slower Q2 Deliveries

The Dow Jones Industrial Average dived 600 points Tuesday, as Tesla stock dropped on weaker-than-expected second quarter deliveries.

Investors Business Daily

Dow Jones Climbs After Worst First Half Since 1962; Chinese EV Makers Report Strong Sales

The Dow Jones Industrial Average rose Friday after the index staged its worst first-half performance since 1962. Chinese EV stocks reported strong sales.

Investors Business Daily

Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years

Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.01% on an annualized basis producing an average annual return of 7.22%. Currently, Johnson & Johnson has a market capitalization of $465.27 billion.

Benzinga

Dow Jones Dives After Key Inflation Report

The Dow Jones Industrial Average dived 575 points Thursday after a key inflation reading, threatening to extend this week's losses.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

What Are Whales Doing With Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

Dow Jones Rallies As Nike Falls On Weak Sales Guidance

The Dow Jones Industrial Average rose 200 points Tuesday, looking to rebound from Monday's losses. Nike stock tumbled on weak guidance.

Investors Business Daily

Dow Jones Futures: What To Do In New Stock Market Rally; Nike Earnings Beat; Tesla Sales Up Next

Dow Jones futures were higher after Monday's stock market fall. Tesla sales are due out amid the new stock market rally.

Investors Business Daily

Dow Jones Reverses Lower As Stock Market Rally Continues; 6 Top Stocks To Buy And Watch

The Dow Jones Industrial Average turned lower Monday as the stock market rally continues. Top stocks to buy and watch include AutoZone.

Investors Business Daily

Dow Up Over 650 Points; Health Care, Biotechs The Winners This Week

The Nasdaq is on pace for a 6.4% gain for the week, while the S&P 500 is up 5.7%.

Investors Business Daily

Dow Jones Gains; Tesla Falls After Elon Musk Reveals These Fears; This Stock Up As Warren Buffett Raises Stake

The Dow Jones moved higher as yields fell. Tesla stock skidded after CEO Elon Musk voiced a warning. A Warren Buffett stock rose.

Investors Business Daily

Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years

Johnson & Johnson (NYSE:JNJ) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 7.34%. Currently, Johnson & Johnson has a market capitalization of $469.49 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Fades Gains Into Close After Powell's Recession Warning

Indexes were on track to close higher Wednesday but slipped back into the negative near the end of the session.

Benzinga

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades.

Investors Business Daily

Dow Jones Up As Powell Gives This Recession Warning; Bitcoin Crumbles Again; 3 Stocks Eye Buy Points

The Dow Jones rose despite a recession warning from Fed Chair Jerome Powell. Bitcoin tumbled again. Apple stock rose after a bullish call.

Benzinga

Looking At Johnson & Johnson's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

COVID-19 vaccines give 'huge boost' to researchers trying to save Tasmanian devils from facial tumour disease

Researchers trying to protect Tasmanian devils are given a "huge boost" in the battle against a deadly disease that has wreaked havoc in the wild, thanks to an unlikely source — the COVID-19 vaccine.

Benzinga

What Are Whales Doing With Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Salon

Novavax's new shot may sway anti-vaxxers

Experts hope the new COVID vaccine, which uses older biotechnology, could help the unvaccinated come around

Investors Business Daily

How Newcomer Arcellx Is Looking To Rival Johnson & Johnson In Cancer

Newcomer Arcellx could rival Johnson & Johnson in multiple myeloma, an analyst said as the biotech popped to a two-month high.

Benzinga

Check Out What Whales Are Doing With JNJ

Benzinga

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.